论文部分内容阅读
目的:探讨针对支原体感染盆腔炎患者,观察选择阿奇霉素+盆腔炎2号完成治疗后的临床效果。方法:选取我院2012年10月-2014年10月支原体感染盆腔炎患者146例。通过随机数表法完成支原体感染盆腔炎患者的随机分组。C1组(观察组73例):临床选择阿奇霉素+盆腔炎2号方进行治疗;C2组(对照组73例):临床选择阿奇霉素进行治疗。对比两组支原体感染盆腔炎患者在临床治疗总有效率、疾病不良反应发生率以及子宫血流动力学指标等方面存在的差异。结果:两组支原体感染盆腔炎患者完成治疗后,在临床治疗总有效率方面,C1组高于C2组盆腔炎患者明显(P<0.05);在疾病不良反应发生率方面,C1组低于C2组盆腔炎患者明显(P<0.05);在患者子宫血流动力学指标方面,C1组优于C2组盆腔炎患者明显(P<0.05)。结论:针对支原体感染盆腔炎患者,临床选择阿奇霉素+盆腔炎2号方进行治疗,能够获得确切疗效,患者临床预后质量可获得显著提高,凸显阿奇霉素与盆腔炎2号两种药物的临床联用价值。
Objective: To investigate the clinical effect of Mycoplasma infection in patients with pelvic inflammatory disease and choose azithromycin + pelvic inflammatory disease 2 after completion of treatment. Methods: A total of 146 patients with pelvic inflammatory disease were selected from October 2012 to October 2014 in our hospital. The patients with pelvic infection of Mycoplasma were randomized to complete randomization by random number table. Group C1 (observation group, 73 cases): clinical choice of azithromycin + pelvic inflammatory disease on the 2nd side for treatment; C2 group (73 cases of control group): clinical choice of azithromycin for treatment. Comparison of two groups of patients with mycoplasma infection of pelvic inflammatory disease in the total effective rate of clinical treatment, the incidence of adverse reactions and uterine uterine hemodynamic indicators exist differences. Results: In the two groups of patients with pelvic infection after pelvic inflammatory disease treatment, the total effective rate of clinical treatment, C1 group was significantly higher than C2 group pelvic inflammatory disease patients (P <0.05); incidence of adverse reactions in the C1 group was lower than C2 Group pelvic inflammatory disease was significantly (P <0.05); in patients with uterine hemodynamic indicators, C1 group was superior to C2 group pelvic inflammatory disease patients (P <0.05). CONCLUSIONS: For mycoplasma infection in patients with pelvic inflammatory disease, the clinical choice of azithromycin + pelvic inflammatory disease No. 2 for treatment, to obtain the exact effect, the quality of clinical prognosis patients can be significantly improved, highlighting the azithromycin and pelvic inflammatory disease two clinical value .